Share
Copied
Novo Nordisk, a global pharmaceutical company specializing in treating diabetes and other chronic diseases, has been successfully operating a research center in China for over 25 years. In recent years, more international tech companies, including pharmaceutical corporations, have been keen to establish their presence in China. On the sidelines of the Zhongguancun Forum, one of China's most high-level forums for science and technology, CGTN spoke to Han Dan, president of Novo Nordisk Research Center China, who shared insights on the fruitful results achieved through collaborations with Chinese research institutes. She also highlighted the enhanced innovation environment in China.
Search Trends
SITEMAP
Copyright © 2023 CGTN. 京ICP备16065310号
Disinformation report hotline: 010-85061466
SITEMAP
Copyright © 2023 CGTN. 京ICP备16065310号
Disinformation report hotline: 010-85061466